embecta to Report Fiscal Second Quarter 2025 Financial Results
Embecta (Nasdaq: EMBC), a global diabetes care company specializing in insulin delivery, has announced it will host a conference call to discuss its fiscal second quarter 2025 financial results on Friday, May 9, 2025, at 8:00 a.m. Eastern Time.
The company will provide an operational update and conduct a question and answer session during the call. Interested parties can access the live webcast through the company's investor relations website at investors.embecta.com. A replay of the webcast will be available from 11:00 a.m. ET on the same day and will remain archived on the website for one year.
Embecta (Nasdaq: EMBC), un'azienda globale specializzata nella cura del diabete e nella somministrazione di insulina, ha annunciato che terrà una conference call per discutere i risultati finanziari del secondo trimestre fiscale 2025 venerdì 9 maggio 2025, alle 8:00 del mattino, ora della costa orientale degli Stati Uniti.
Durante la chiamata, l'azienda fornirà un aggiornamento operativo e risponderà alle domande. Gli interessati potranno seguire la diretta streaming attraverso il sito web per gli investitori all'indirizzo investors.embecta.com. La registrazione della trasmissione sarà disponibile a partire dalle 11:00 ET dello stesso giorno e resterà archiviata sul sito per un anno.
Embecta (Nasdaq: EMBC), una empresa global especializada en el cuidado de la diabetes y en la administración de insulina, ha anunciado que realizará una conferencia telefónica para discutir sus resultados financieros del segundo trimestre fiscal de 2025 el viernes 9 de mayo de 2025 a las 8:00 a.m., hora del este de EE.UU.
Durante la llamada, la empresa ofrecerá una actualización operativa y una sesión de preguntas y respuestas. Los interesados podrán acceder a la transmisión en vivo a través del sitio web de relaciones con inversionistas en investors.embecta.com. La repetición de la transmisión estará disponible a partir de las 11:00 a.m. ET del mismo día y permanecerá archivada en el sitio durante un año.
Embecta (나스닥: EMBC)는 인슐린 전달을 전문으로 하는 글로벌 당뇨병 관리 기업으로, 2025 회계연도 2분기 실적에 대해 2025년 5월 9일 금요일 동부 표준시 오전 8시에 컨퍼런스 콜을 개최한다고 발표했습니다.
이번 콜에서는 운영 현황 업데이트와 질의응답 시간이 진행됩니다. 관심 있는 분들은 회사 투자자 관계 웹사이트 investors.embecta.com을 통해 생중계에 접속할 수 있습니다. 생중계 녹화본은 같은 날 오전 11시부터 제공되며, 웹사이트에 1년간 보관됩니다.
Embecta (Nasdaq : EMBC), une entreprise mondiale spécialisée dans les soins du diabète et la distribution d'insuline, a annoncé qu'elle tiendra une conférence téléphonique pour discuter de ses résultats financiers du deuxième trimestre fiscal 2025 le vendredi 9 mai 2025 à 8h00, heure de l'Est.
Lors de l'appel, la société fournira une mise à jour opérationnelle et une session de questions-réponses. Les personnes intéressées pourront accéder à la diffusion en direct via le site web des relations investisseurs à investors.embecta.com. Le replay sera disponible à partir de 11h00 ET le même jour et restera archivé sur le site pendant un an.
Embecta (Nasdaq: EMBC), ein weltweit tätiges Unternehmen im Bereich Diabetesversorgung mit Schwerpunkt auf Insulinabgabe, hat angekündigt, am Freitag, den 9. Mai 2025, um 8:00 Uhr Eastern Time eine Telefonkonferenz zur Diskussion der finanziellen Ergebnisse des zweiten Fiskalquartals 2025 abzuhalten.
Das Unternehmen wird während des Anrufs ein operatives Update geben und eine Fragerunde durchführen. Interessierte können den Live-Webcast über die Investor-Relations-Website des Unternehmens unter investors.embecta.com verfolgen. Eine Aufzeichnung des Webcasts ist ab 11:00 Uhr ET am selben Tag verfügbar und wird für ein Jahr auf der Website archiviert.
- None.
- None.
PARSIPPANY, N.J., April 21, 2025 (GLOBE NEWSWIRE) -- Embecta Corp. (“embecta”) (Nasdaq: EMBC), a global diabetes care company with a 100-year legacy in insulin delivery, will host a conference call to discuss its fiscal second quarter 2025 financial results, provide an operational update, and host a question and answer session, at 8:00 a.m. Eastern Time (ET) on Friday, May 9, 2025.
Those who would like to participate may access the live webcast here, or access the teleconference here. The live webcast can also be accessed via the company’s website at investors.embecta.com.
A webcast replay of the call will be available beginning at 11:00 a.m. ET on May 9, 2025, via the embecta investor relations website and archived on the website for one year.
About embecta
embecta is a global diabetes care company that is leveraging its 100-year legacy in insulin delivery to empower people with diabetes to live their best life through innovative solutions, partnerships and the passion of approximately 2,000 employees around the globe. For more information, visit embecta.com or follow our social channels on LinkedIn, Facebook, and Instagram.
| Contacts: | |
| Media | Investors |
| Christian Glazar | Pravesh Khandelwal |
| Sr. Director, Corporate Communications | VP, Head of Investor Relations |
| 908-821-6922 | 551-264-6547 |
| Contact Media Relations | Contact IR |
FAQ
When will Embecta (EMBC) release its Q2 2025 earnings?
How can investors access Embecta's Q2 2025 earnings call?
How long will Embecta's Q2 2025 earnings call replay be available?
What topics will be covered in Embecta's (EMBC) Q2 2025 earnings call?
